This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
  • 00
  • 00
  • 00
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Alterras Therapeutics


Alterras Therapeutics is a young preclinical startup in Vienna developing therapies acting on a promising new pathway: the alternative RAS (renin angiotensin system). Our current indication is pulmonary hypertension - an orphan disease with high medical need and considerable market size. Our lead compound was not only able to match the current clinical standard in vivo, but even outperformed it in some parameters. We are currently investigating other RAS driven diseases to broaden our portfolio.